Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Responding to mental health needs after terror attacks.

Allsopp K, Brewin CR, Barrett A, Williams R, Hind D, Chitsabesan P, French P.

BMJ. 2019 Aug 13;366:l4828. doi: 10.1136/bmj.l4828. No abstract available.

PMID:
31409609
2.

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination.

Wilder-Smith A, Barrett A, Vannice K, Hombach J.

Ann Intern Med. 2019 Jul 16;171(2):145-146. doi: 10.7326/L19-0196. No abstract available.

PMID:
31307078
3.

Terrestrial Bird Migration and West Nile Virus Circulation, United States.

Swetnam D, Widen SG, Wood TG, Reyna M, Wilkerson L, Debboun M, Symonds DA, Mead DG, Beaty BJ, Guzman H, Tesh RB, Barrett ADT.

Emerg Infect Dis. 2018 Dec;24(12):2184-2194. doi: 10.3201/eid2412.180382.

4.

Within- and Between-Session Prefrontal Cortex Response to Virtual Reality Exposure Therapy for Acrophobia.

Landowska A, Roberts D, Eachus P, Barrett A.

Front Hum Neurosci. 2018 Nov 1;12:362. doi: 10.3389/fnhum.2018.00362. eCollection 2018.

5.

Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses.

Collins ND, Beck AS, Widen SG, Wood TG, Higgs S, Barrett ADT.

MBio. 2018 Oct 30;9(5). pii: e01871-18. doi: 10.1128/mBio.01871-18.

6.

West Nile in Europe: an increasing public health problem.

Barrett ADT.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay096. No abstract available.

PMID:
30289526
7.

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, Cravioto A, Farrar J, Nolan TM.

Lancet Infect Dis. 2019 Jan;19(1):e31-e38. doi: 10.1016/S1473-3099(18)30494-8. Epub 2018 Sep 5. Review.

PMID:
30195995
8.

Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains.

Beck AS, Wood TG, Widen SG, Thompson JK, Barrett ADT.

Sci Rep. 2018 Sep 7;8(1):13408. doi: 10.1038/s41598-018-31085-2.

9.

The reemergence of yellow fever.

Barrett ADT.

Science. 2018 Aug 31;361(6405):847-848. doi: 10.1126/science.aau8225. Epub 2018 Aug 23. No abstract available.

PMID:
30139914
10.

Developing Zika vaccines: the lessons for disease X.

Barrett ADT.

Genome Med. 2018 Jun 26;10(1):47. doi: 10.1186/s13073-018-0561-2.

11.

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation.

Barrett ADT.

NPJ Vaccines. 2018 Jun 11;3:24. doi: 10.1038/s41541-018-0061-9. eCollection 2018. Review.

12.

Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.

Milligan GN, White M, Zavala D, Pyles RB, Sarathy VV, Barrett ADT, Bourne N.

Antiviral Res. 2018 Jun;154:104-109. doi: 10.1016/j.antiviral.2018.04.012. Epub 2018 Apr 14.

13.

Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development.

Reece LM, Beasley DW, Milligan GN, Sarathy VV, Barrett AD.

Curr Opin Virol. 2018 Apr;29:72-78. doi: 10.1016/j.coviro.2018.03.005. Epub 2018 Apr 9. Review.

PMID:
29642053
14.

Home range utilization by chacma baboon (Papio ursinus) troops on Suikerbosrand Nature Reserve, South Africa.

Slater K, Barrett A, Brown LR.

PLoS One. 2018 Mar 29;13(3):e0194717. doi: 10.1371/journal.pone.0194717. eCollection 2018.

15.

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.

Hallam HJ, Hallam S, Rodriguez SE, Barrett ADT, Beasley DWC, Chua A, Ksiazek TG, Milligan GN, Sathiyamoorthy V, Reece LM.

NPJ Vaccines. 2018 Mar 20;3:11. doi: 10.1038/s41541-018-0049-5. eCollection 2018. Review.

16.

Characterization of a murine model of non-lethal, symptomatic dengue virus infection.

Sarathy VV, White M, Li L, Kaiser JA, Campbell GA, Milligan GN, Bourne N, Barrett ADT.

Sci Rep. 2018 Mar 20;8(1):4900. doi: 10.1038/s41598-018-22618-w.

17.

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.

Gerson JE, Farmer KM, Henson N, Castillo-Carranza DL, Carretero Murillo M, Sengupta U, Barrett A, Kayed R.

Mol Neurodegener. 2018 Mar 15;13(1):13. doi: 10.1186/s13024-018-0245-9.

18.

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Vannice KS, Wilder-Smith A, Barrett ADT, Carrijo K, Cavaleri M, de Silva A, Durbin AP, Endy T, Harris E, Innis BL, Katzelnick LC, Smith PG, Sun W, Thomas SJ, Hombach J.

Vaccine. 2018 Jun 7;36(24):3411-3417. doi: 10.1016/j.vaccine.2018.02.062. Epub 2018 Mar 7.

19.

Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells.

Luo H, Winkelmann ER, Fernandez-Salas I, Li L, Mayer SV, Danis-Lozano R, Sanchez-Casas RM, Vasilakis N, Tesh R, Barrett AD, Weaver SC, Wang T.

Antiviral Res. 2018 Mar;151:55-62. doi: 10.1016/j.antiviral.2018.01.003. Epub 2018 Jan 10.

20.

Zika vaccine candidates progress through nonclinical development and enter clinical trials.

Barrett ADT.

NPJ Vaccines. 2016 Nov 10;1:16023. doi: 10.1038/npjvaccines.2016.23. eCollection 2016. No abstract available.

21.

The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database.

Rawlings ND, Barrett AJ, Thomas PD, Huang X, Bateman A, Finn RD.

Nucleic Acids Res. 2018 Jan 4;46(D1):D624-D632. doi: 10.1093/nar/gkx1134.

22.

Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection.

Xia L, Tang A, Meng W, Freed DC, He L, Wang D, Li F, Li L, Xiong W, Gui X, Schultz RD, Chen H, He X, Swoyer R, Ha S, Liu Y, Morris CD, Zhou Y, Wang IM, Zhao Q, Luo W, Xia N, Espeseth AS, Hazuda DJ, Rupp RE, Barrett AD, Zhang N, Zhu J, Fu TM, An Z.

Oncotarget. 2017 Jun 3;8(43):73654-73669. doi: 10.18632/oncotarget.18359. eCollection 2017 Sep 26.

23.

A lethal model of disseminated dengue virus type 1 infection in AG129 mice.

Milligan GN, Sarathy VV, White MM, Greenberg MB, Campbell GA, Pyles RB, Barrett ADT, Bourne N.

J Gen Virol. 2017 Oct;98(10):2507-2519. doi: 10.1099/jgv.0.000923. Epub 2017 Sep 27.

24.

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage.

Shan C, Muruato AE, Jagger BW, Richner J, Nunes BTD, Medeiros DBA, Xie X, Nunes JGC, Morabito KM, Kong WP, Pierson TC, Barrett AD, Weaver SC, Rossi SL, Vasconcelos PFC, Graham BS, Diamond MS, Shi PY.

Nat Commun. 2017 Sep 22;8(1):676. doi: 10.1038/s41467-017-00737-8.

25.

Virulence determinants of West Nile virus: how can these be used for vaccine design?

Kaiser JA, Wang T, Barrett AD.

Future Virol. 2017 May;12(5):283-295. doi: 10.2217/fvl-2016-0141. Epub 2017 Apr 28. Review.

26.

Genomic Characterization of Crimean-Congo Hemorrhagic Fever Virus in Hyalomma Tick from Spain, 2014.

Cajimat MNB, Rodriguez SE, Schuster IUE, Swetnam DM, Ksiazek TG, Habela MA, Negredo AI, Estrada-Peña A, Barrett ADT, Bente DA.

Vector Borne Zoonotic Dis. 2017 Oct;17(10):714-719. doi: 10.1089/vbz.2017.2190. Epub 2017 Aug 24.

PMID:
28836897
27.

Open Online Courses in Public Health: experience from Peoples-uni.

Heller RF, Zurynski R, Barrett A, Oaiya O, Madhok R.

Version 2. F1000Res. 2017 Feb 21 [revised 2017 Jan 1];6:170. doi: 10.12688/f1000research.10728.2. eCollection 2017.

28.

p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Müller cells following Zika virus infection.

Zhu S, Luo H, Liu H, Ha Y, Mays ER, Lawrence RE, Winkelmann E, Barrett AD, Smith SB, Wang M, Wang T, Zhang W.

Antiviral Res. 2017 Sep;145:70-81. doi: 10.1016/j.antiviral.2017.07.012. Epub 2017 Jul 21.

29.

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.

Richner JM, Jagger BW, Shan C, Fontes CR, Dowd KA, Cao B, Himansu S, Caine EA, Nunes BTD, Medeiros DBA, Muruato AE, Foreman BM, Luo H, Wang T, Barrett AD, Weaver SC, Vasconcelos PFC, Rossi SL, Ciaramella G, Mysorekar IU, Pierson TC, Shi PY, Diamond MS.

Cell. 2017 Jul 13;170(2):273-283.e12. doi: 10.1016/j.cell.2017.06.040.

30.

A DENV-2-type-specific monoclonal antibody binds to the DENV-complex-reactive antigenic site on envelope protein domain 3.

Sarathy VV, Pitcher TJ, Gromowski GD, Roehrig JT, Barrett ADT.

J Gen Virol. 2017 Jun;98(6):1299-1304. doi: 10.1099/jgv.0.000785. Epub 2017 Jun 20.

PMID:
28631593
31.

A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models.

Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, Wakamiya M, Tesh RB, Barrett AD, Wang T, Weaver SC, Vasconcelos PFC, Rossi SL, Shi PY.

Nat Med. 2017 Jun;23(6):763-767. doi: 10.1038/nm.4322. Epub 2017 Apr 10.

32.

Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.

Barrett ADT.

Vaccine. 2017 Oct 20;35(44):5951-5955. doi: 10.1016/j.vaccine.2017.03.032. Epub 2017 Mar 30. Review.

PMID:
28366605
33.

Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day.

Collins ND, Barrett AD.

Curr Infect Dis Rep. 2017 Mar;19(3):14. doi: 10.1007/s11908-017-0566-9. Review.

34.

MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection.

Luo H, Winkelmann E, Xie G, Fang R, Peng BH, Li L, Lazear HM, Paessler S, Diamond MS, Gale M Jr, Barrett AD, Wang T.

J Virol. 2017 Feb 28;91(6). pii: e02097-16. doi: 10.1128/JVI.02097-16. Print 2017 Mar 15.

35.

Transstadial Transmission and Long-term Association of Crimean-Congo Hemorrhagic Fever Virus in Ticks Shapes Genome Plasticity.

Xia H, Beck AS, Gargili A, Forrester N, Barrett AD, Bente DA.

Sci Rep. 2016 Oct 24;6:35819. doi: 10.1038/srep35819.

36.

Outcomes from a pilot psychological therapies service for UK military veterans.

Clarkson P, Giebel CM, Challis D, Duthie P, Barrett A, Lambert H.

Nurs Open. 2016 Jun 28;3(4):227-235. eCollection 2016 Oct.

37.

Differential Infectivities among Different Japanese Encephalitis Virus Genotypes in Culex quinquefasciatus Mosquitoes.

Huang YS, Hettenbach SM, Park SL, Higgs S, Barrett AD, Hsu WW, Harbin JN, Cohnstaedt LW, Vanlandingham DL.

PLoS Negl Trop Dis. 2016 Oct 5;10(10):e0005038. doi: 10.1371/journal.pntd.0005038. eCollection 2016 Oct.

38.

Fast-Track Zika Vaccine Development - Is It Possible?

Thomas SJ, L'Azou M, Barrett AD, Jackson NA.

N Engl J Med. 2016 Sep 29;375(13):1212-6. doi: 10.1056/NEJMp1609300. No abstract available.

39.

Zika Virus: Diagnosis, Therapeutics, and Vaccine.

Shan C, Xie X, Barrett AD, Garcia-Blanco MA, Tesh RB, Vasconcelos PF, Vasilakis N, Weaver SC, Shi PY.

ACS Infect Dis. 2016 Mar 11;2(3):170-2. doi: 10.1021/acsinfecdis.6b00030. Epub 2016 Mar 3.

PMID:
27623030
40.

Invasion Dynamics of Teratogenic Infections in Light of Rubella Control: Implications for Zika Virus.

Metcalf CJ, Barrett A.

PLoS Curr. 2016 Aug 16;8. pii: ecurrents.outbreaks.873427b89ab9c75eb90c8ddb8d8c7c90. doi: 10.1371/currents.outbreaks.873427b89ab9c75eb90c8ddb8d8c7c90.

41.

Vaccinology in the twenty-first century.

Barrett ADT.

NPJ Vaccines. 2016 Jul 28;1:16009. doi: 10.1038/npjvaccines.2016.9. eCollection 2016. No abstract available.

42.

Research and development of Zika virus vaccines.

Dawes BE, Smalley CA, Tiner BL, Beasley DW, Milligan GN, Reece LM, Hombach J, Barrett AD.

NPJ Vaccines. 2016 Jul 28;1:16007. doi: 10.1038/npjvaccines.2016.7. eCollection 2016.

43.

Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand.

Barrett AD.

N Engl J Med. 2016 Jul 28;375(4):301-3. doi: 10.1056/NEJMp1606997. Epub 2016 Jun 8. No abstract available.

44.

An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors.

Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, Azar SR, Yang Y, Tesh RB, Bourne N, Barrett AD, Vasilakis N, Weaver SC, Shi PY.

Cell Host Microbe. 2016 Jun 8;19(6):891-900. doi: 10.1016/j.chom.2016.05.004. Epub 2016 May 16.

45.

A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Calvert AE, Dixon KL, Piper J, Bennett SL, Thibodeaux BA, Barrett AD, Roehrig JT, Blair CD.

Antiviral Res. 2016 Jul;131:92-9. doi: 10.1016/j.antiviral.2016.04.013. Epub 2016 Apr 26.

46.

The Impact of Voluntary and Involuntary Retirement on Mental Health: Evidence from Older Irish Adults.

Mosca I, Barrett A.

J Ment Health Policy Econ. 2016 Mar;19(1):33-44.

PMID:
27084792
47.

Introduction.

Coller BA, Barrett AD, Thomas SJ.

Vaccine. 2015 Dec 10;33(50):7049-50. doi: 10.1016/j.vaccine.2015.10.087. Epub 2015 Oct 24. No abstract available.

PMID:
26597033
48.

Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice.

Xie G, Luo H, Pang L, Peng BH, Winkelmann E, McGruder B, Hesse J, Whiteman M, Campbell G, Milligan GN, Cong Y, Barrett AD, Wang T.

J Virol. 2015 Nov 18;90(3):1333-44. doi: 10.1128/JVI.02488-15. Print 2016 Feb 1.

49.

Susceptibility of a North American Culex quinquefasciatus to Japanese Encephalitis Virus.

Huang YJ, Harbin JN, Hettenbach SM, Maki E, Cohnstaedt LW, Barrett AD, Higgs S, Vanlandingham DL.

Vector Borne Zoonotic Dis. 2015 Nov;15(11):709-11. doi: 10.1089/vbz.2015.1821.

PMID:
26565775
50.

Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.

Toole B, Gechtman C, Dreier J, Kuhn J, Gutierrez MR, Barrett A, Niederau C.

Clin Lab. 2015;61(9):1303-15.

PMID:
26554251

Supplemental Content

Loading ...
Support Center